-
Deep Learning for iPSC-CM Cardiotoxicity Screening
2026-09-21
Grafton et al. developed a high-content phenotypic screening strategy that combines human induced pluripotent stem cell-derived cardiomyocytes with deep-learning image analysis to identify cardiotoxic patterns early in drug discovery. The approach produced a single-parameter toxicity score across chemically diverse compounds, offering a scalable complement to conventional target-specific assays while retaining important limitations of in vitro cardiac models.
-
RSAD2 at the Maternal-Fetal Interface in SLE
2026-09-21
Ding et al. identify RSAD2 as a pathogenic interferon-stimulated gene that links excessive type I interferon activity with placental lipid accumulation, vascular injury, and adverse pregnancy outcomes in systemic lupus erythematosus. Their human and mouse evidence supports RSAD2 as a mechanistic target, while also defining important limits for translating the findings into therapeutic or biochemical workflows.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-20
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines immune challenges with targeted metabolic interventions and cytokine measurement. The approach preserves a physiologically complex blood environment while enabling reproducible comparisons of how anabolic and catabolic pathway modulation shapes immune responses.
-
AZD1480: Mapping the IL-6–JAK2–STAT3 Escape Axis
2026-09-19
AZD1480 is a potent JAK2 inhibitor for dissecting tumor-intrinsic STAT3 signaling. This article develops a causal, assay-centered framework for testing how immune-metabolic interventions may create an IL-6–JAK2–STAT3 survival response.
-
Human SAN-Plexus Assembloids and Pacemaker Maturation
2026-09-18
The reference study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like tissues to model innervation-associated pacemaker maturation. By integrating electrophysiological analysis with human SAN spatial transcriptomics, it identifies a CGPO-derived prosaposin–GPR37 signaling program that promotes SAN-like maturation and provides a human platform for studying neuro-cardiac mechanisms in cardiovascular research.
-
Dual DNA–RNA Methylation Drives EGFR-TKI Resistance
2026-09-18
The reference study identifies a coordinated DNA 5-mC and RNA m5C regulatory circuit that shifts MZF1 splice-variant expression during acquired EGFR-TKI resistance in non-small-cell lung cancer. Its findings connect UHRF1/DNMT1 and NSUN7/YBX1 activity with splicing-factor selection, MZF1 function, and pharmacological resensitization.
-
AO/PI Double Staining Kit for Glioma Organoids
2026-09-17
Use the AO/PI Double Staining Kit to separate viable, apoptotic-like, and membrane-compromised cells during organoid drug screening. This guide connects rapid fluorescent readouts with glioma microenvironment models, matched controls, flow cytometry, microscopy, and practical troubleshooting.
-
Live-Dead Bacterial Staining Kit for Nanomaterials
2026-09-17
Use the Live-Dead Bacterial Staining Kit to connect membrane integrity with antibacterial performance in nanoparticle, biofilm, and stress-response studies. Its NucGreen dye and EthD-III dual-signal design supports rapid bacterial viability assays while revealing workflow limitations that can otherwise obscure treatment effects.
-
Catalpol Workflows for Translational Research
2026-09-16
Catalpol, also known as Catalpinoside, supports mechanism-led studies spanning neuroprotection research, vascular injury, bone loss, and liver fibrosis. This practical guide connects dose selection, pathway readouts, formulation control, and model-specific troubleshooting for more reproducible experiments.
-
CCT007093: PPM1D Inhibitor Workflow
2026-09-16
This scenario-based guide explains how CCT007093, SKU B3274, can support controlled studies of PPM1D/WIP1, p38 signaling, and cell viability. It covers solvent handling, time-course design, mechanistic controls, interpretation across models, and practical criteria for selecting a reliable chemical inhibitor.
-
4-Ethylphenyl Sulfate: Assay Workflows
2026-09-15
4-Ethylphenyl sulfate supports parallel studies of microbiota-linked neurobehavioral phenotypes, renal dysfunction, and toxin adsorption. This practical guide connects compound handling with matrix-aware quantitation, cyclodextrin-coated adsorbent screens, and troubleshooting strategies for reproducible results.
-
Alosetron in Gut Assays: From 5-HT3 to Cell Fate
2026-09-15
Alosetron provides a selective way to interrogate 5-HT3 receptor signaling in gastrointestinal models. This article distinguishes receptor-level perturbation from CDC42–YAP–mTOR mechanisms and develops a rigorous framework for interpreting intestinal stem-cell assays.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-09-14
The Hoechst 33342/PI Double Staining Kit (K2237) supports microscopy-based discrimination of normal, apoptotic-like, and necrotic cell populations by combining nuclear fluorescence with membrane-integrity assessment. It is intended for basic scientific research and should not be used as a diagnostic, clinical, or standalone mechanistic assay.
-
Letrozole: From Aromatase Mechanism to Translation
2026-09-14
Letrozole is more than a potent non-steroidal aromatase inhibitor: it is a translational tool for connecting estrogen synthesis, ERα biology, endocrine feedback, and context-dependent neural phenotypes. This article outlines how to build more informative assays with Letrozole, position aromatase inhibition within the breast cancer research landscape, and avoid confusing upstream estrogen suppression with direct estrogen-receptor modulation.
-
0.4% Trypan Blue Solution: Cell Viability Guide
2026-09-13
0.4% Trypan Blue Solution supports rapid live/dead cell discrimination and cell viability measurement during cell counting, culture maintenance, and endpoint cytotoxicity workflows. It is intended for research use only, not for diagnostic or medical applications, and should be interpreted as a membrane-integrity assay rather than a complete apoptosis or necrosis classification method.